TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. September 30, 2005
TCL Archive Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall September 15, 1978